Trufreeze
Payments companies reported to CMS as associated with Trufreeze. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Trufreeze, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Trufreeze
These are the largest totals companies reported as associated with Trufreeze. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Toufic Kachaamy | Scottsdale, AZ | Gastroenterology (Internal Medicine) | $53,979.60 |
| Sonali Sethi | New York, NY | Pulmonary Disease | $48,718.53 |
| Otis Rickman | Nashville, TN | Pulmonary Disease | $32,027.58 |
| Ken Yoneda | Sacramento, CA | Critical Care Medicine (Internal Medicine) | $28,530.16 |
| Neil Sharma | Gilbert, AZ | Gastroenterology (Internal Medicine) | $27,084.70 |
| Adnan Majid | Boston, MA | Pulmonary Disease | $21,695.35 |
| John Erikson Yap | St George, UT | Gastroenterology (Internal Medicine) | $16,583.92 |
| Laura Frye | Salt Lake City, UT | Critical Care Medicine (Internal Medicine) | $14,711.11 |
| Joseph Spataro | Richmond, VA | Gastroenterology (Internal Medicine) | $13,555.66 |
| Tilak Shah | Richmond, VA | Gastroenterology (Internal Medicine) | $11,554.64 |
Prescribed Trufreeze?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.